Cargando…
The immune landscape of hepatocellular carcinoma-where we are?
Hepatocellular carcinoma (HCC) is one of the most common types of cancer diagnosed worldwide. After a decade of stagnation, several novel compounds have recently been shown to be effective in the treatment of HCC. Since immunotherapy is associated with important clinical benefits in some, but not al...
Autores principales: | Gryziak, Maciej, Wozniak, Krzysztof, Kraj, Leszek, Rog, Letycja, Stec, Rafal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555061/ https://www.ncbi.nlm.nih.gov/pubmed/36245826 http://dx.doi.org/10.3892/ol.2022.13530 |
Ejemplares similares
-
Oncometabolites—A Link between Cancer Cells and Tumor Microenvironment
por: Baryła, Maksymilian, et al.
Publicado: (2022) -
The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
por: Hu, Xin, et al.
Publicado: (2022) -
Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
por: Pelizzaro, Filippo, et al.
Publicado: (2021) -
Hepatocellular Carcinoma in Pakistan: Where do We Stand?
por: Butt, Amna Subhan, et al.
Publicado: (2012) -
Immunotherapy with Checkpoint Inhibitors for Hepatocellular Carcinoma: Where Are We Now?
por: Tovoli, Francesco, et al.
Publicado: (2020)